Breast Implants Market Growth Is Anticipated To Reach USD 2.0 Billion By 2025

Increasing focus toward enhancement of physical appearance has led to the growth of breast implants market.

Breast reconstructions are being highly adopted by women in order to enhance their physical appearances. This kind of surgery involves esthetic repair of any damage taking place after implantation procedure. According to the American Society of Plastic Surgeons, in 2015, nearly 106,000 breast reconstruction procedures have been performed in the U.S. Thus, such huge number of cases are expected to drive the growth of the market.

Breast implants are used post mastectomy to enhance esthetic appeal. Breast augmentation is another procedure requiring the application of these implants. Esthetic appeal plays an important role in increasing the demand for these procedures, thereby, making the cosmetic industry lucrative for the target population.

View summary of this report, Click Here 

Further key findings from the study suggest:

• In 2016, silicone implants dominated the market due to the fact that it has a natural resemblance to the breast tissue
• Saline implants are anticipated to showcase significant growth over the forecast period due to lesser risk of complications during implant rupture
• Round-shaped implants held the largest market share in 2016 owing to less complications involved during implant rotation
• Anatomical-shaped devices are expected to showcase lucrative growth in the future due to their design that has a natural appearance, which make them ideal for breast enhancement
• The cosmetic surgery segment dominated the market in 2016 due to the growing number of cosmetic procedures conducted globally
• North America dominated the market in 2016 due to rising number of augmentation procedures of this organ conducted in the U.S.
• Asia Pacific is expected to display lucrative growth over the forecast period owing to immense opportunities in the field of medical tourism in this region
• Some of the key players include ALLERGAN; Sientra, Inc.; GC Aesthetics; Mentor Worldwide LLC; Establishment Labs S.A.; Polytech Health & Aesthetics GmbH; GROUPE SEBBIN SAS; HANSBIOMED CO. LTD; Laboratoires Arion; and Shanghai Kangning Medical Supplies Ltd.

Click Here For Access Full Report : https://goo.gl/4s8DSz

Endoscopic Vessel Harvesting Systems Market Growth Is Expected To Reach USD 3.4 Billion By 2025

Growing inclination of the patient population toward minimally invasive cardiac surgeries is one of the key factors expected to drive the market in the coming few years.

The introduction of endoscopic vessel harvesting technology in the field of cardiac surgery was a significant milestone in 1996. According to estimates by the Texas Heart Institute, every year over 200,000 procedures were performed in the U.S. Also, based on the statistics published by the department of surgery (Washington University School of Medicine in St. Louis), they perform Coronary Artery Bypass Grafting (CABG) surgeries on approximately 0.5 million people very year. The growing demand for these procedures and technologically advanced surgical procedures are among few factors anticipated to boost the market over the forecast period.

The presence of favorable reimbursement policies in the U.S. pertaining to CABG surgeries is anticipated to increase the number these surgeries. On July 2016, the Department of Health & Human Services announced that it will begin implementing bundled payment models for high-quality, coordinated cardiac and hip fracture care. The market is highly concentrated with a limited number of products and market players operating in this space. Many studies stated that the open vessels harvesting technique is as effective as minimally invasive vessels harvesting technique. However, the growing awareness regarding benefits of Endoscopic Vessels Harvesting (EVH), such as minimally invasive nature, less complications, and quick recuperation are some of the factors that are anticipated to propel its growth during the forecast period.

View summary of this report, Click Here 

Further Key Findings From the Report Suggest:

• The global endoscopic vessel harvesting system market size was estimated at USD 1,881.7 million in 2016 and is expected to grow at a CAGR of 6.1% from 2017 to 2025
• Reusable EVH systems emerged as the largest product segment in 2015 and is estimated to generate revenue over USD 2,136.0 million by 2025
• Global disposable EVH systems was USD 639.3 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. The regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including MAQUET Holding B.V. & Co. KG; CARDIO MEDICAL GmbH; Terumo Cardiovascular Group; Med Europe S.r.l. (Elite Life Care); LivaNova plc. (Sorin and Cyberonics); and Saphena Medical, Inc. dominated the global endoscopic vessels harvesting systems market. 

Click Here For Full Report :      https://goo.gl/vSuZpy